Tag: Cancer: Skin
Topical Immunotx for Actinic Keratosis May Prevent Cancer
Fewer patients treated with calcipotriol plus 5-FU developed SCC on treated face, scalp within three years
Tumor Control Durable With Pembrolizumab in Merkel Cell Cancer
28 of 50 advanced MCC patients responded; 24-month overall survival rate was 68.7 percent
Melanoma Survival Varies Among U.S. States
Worse survival in states with more physicians; higher death rates in states with lower incidence
Health Care Screening Practices Impact Skin Cancer Diagnosis
Likelihood of being diagnosed with skin cancer increased for those undergoing health care screening
New AAP Guideline Available for Infantile Hemangioma Treatment
Early intervention and/or referral recommended for potentially problematic infantile hemangiomas
AAD Releases New Guidelines for the Tx of Cutaneous Melanoma
Guidelines recommend surgical excision as primary treatment modality, emphasize individualized care
FDA Approves New Treatment for Squamous Cell Carcinoma
Libtayo is the sixth FDA-approved immune checkpoint inhibitor targeting the PD-1 pathway
Novel Immunotherapy May Up Survival in Melanoma Brain Mets
Findings in patients receiving checkpoint blockade immunotherapy for melanoma brain metastases
Review: Treatments for Primary Basal Cell Carcinoma Compared
Similarly low recurrence rates for excision, Mohs sx, curettage and diathermy, external-beam radiation
Nivolumab + Ipilimumab Shows Efficacy for Untreated Brain Mets
Findings from open-label, phase 2 study in patients with melanoma and untreated brain metastases
